Financhill
Back

Arcturus Therapeutics Holdings Stock Price Chart

Your bank account could be compromised

Follow these three simple steps to protect your savings now.
Sell
43

ARCT
Arcturus Therapeutics Holdings

Last Price:
22.89
Seasonality Move:
3.97%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight buying pressure.

Arcturus Therapeutics Holdings Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 22.26 Buy
20-day SMA: 25.34 Sell
50-day SMA: 29.4 Sell
200-day SMA: 29.39 Sell
8-day EMA: 22.92 Buy
20-day EMA: 25.34 Sell
50-day EMA: 28.37 Sell
200-day EMA: 29.6 Sell

Arcturus Therapeutics Holdings Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.59 Sell
Relative Strength Index (14 RSI): 41.37 Sell
Chaikin Money Flow: 215879 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.67 - 33.51) Sell
Bollinger Bands (100): (26.02 - 36.96) Sell

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Arcturus Therapeutics Holdings Stock

Is Arcturus Therapeutics Holdings Stock a Buy?

ARCT Technical Analysis vs Fundamental Analysis

Sell
43
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy or a Sell?

Arcturus Therapeutics Holdings Stock Info

Market Cap:
640.3M
Price in USD:
23.78
Share Volume:
457.41K

Arcturus Therapeutics Holdings 52-Week Range

52-Week High:
45.00
52-Week Low:
17.52
Sell
43
Arcturus Therapeutics Holdings (ARCT) is a Sell

Arcturus Therapeutics Holdings Share Price Forecast

Is Arcturus Therapeutics Holdings Stock a Buy?

Fundamental Analysis of Arcturus Therapeutics Holdings

Is Arcturus Therapeutics Holdings a good investment?

  • Analysts estimate an earnings decrease this quarter of $1.08 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.63 per share, and an increase next year of $1.19 per share.

Technical Analysis of Arcturus Therapeutics Holdings

Should I short Arcturus Therapeutics Holdings stock?

* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.